Basilea Pharmaceutica AG
BPMUF
$67.75
$6.4110.45%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 161.41M | 145.22M | 133.21M | 142.90M | 70.07M |
| Total Receivables | 72.08M | 64.85M | 64.21M | 68.88M | 54.47M |
| Inventory | 28.45M | 25.60M | 34.88M | 37.42M | 34.92M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 11.51M | 10.36M | 11.49M | 12.32M | 13.05M |
| Total Current Assets | 273.45M | 246.02M | 243.78M | 261.52M | 172.51M |
|
|
|||||
| Total Current Assets | 273.45M | 246.02M | 243.78M | 261.52M | 172.51M |
| Net Property, Plant & Equipment | 22.04M | 19.83M | 20.94M | 22.47M | 21.60M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 421.20K | 379.00K | 412.70K | 442.80K | 526.40K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.99M | 15.29M | 19.31M | 20.72M | 15.32M |
| Total Assets | 312.90M | 281.52M | 284.45M | 305.15M | 209.95M |
|
|
|||||
| Total Accounts Payable | 12.48M | 11.23M | 12.68M | 13.60M | 12.77M |
| Total Accrued Expenses | 20.41M | 18.36M | 23.73M | 25.45M | 12.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.59M | 2.33M | 2.28M | 2.44M | 2.29M |
| Total Finance Division Other Current Liabilities | 7.76M | 6.98M | 11.60M | 12.44M | 14.19M |
| Total Other Current Liabilities | 7.76M | 6.98M | 11.60M | 12.44M | 14.19M |
| Total Current Liabilities | 43.25M | 38.91M | 50.27M | 53.93M | 42.04M |
|
|
|||||
| Total Current Liabilities | 43.25M | 38.91M | 50.27M | 53.93M | 42.04M |
| Long-Term Debt | 103.09M | 92.75M | 105.84M | 113.54M | 106.48M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 16.02M | 14.41M | 15.12M | 16.22M | 16.36M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 20.84M | 18.75M | 23.83M | 25.57M | 26.39M |
| Total Liabilities | 183.19M | 164.82M | 195.07M | 209.26M | 191.27M |
|
|
|||||
| Common Stock & APIC | 1.34B | 1.20B | 1.17B | 1.26B | 1.18B |
| Retained Earnings | -1.14B | -1.03B | -1.02B | -1.09B | -1.09B |
| Treasury Stock & Other | -66.88M | -60.17M | -62.29M | -66.82M | -67.91M |
| Total Common Equity | 129.71M | 116.70M | 89.39M | 95.89M | 18.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 129.71M | 116.70M | 89.39M | 95.89M | 18.68M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 129.71M | 116.70M | 89.39M | 95.89M | 18.68M |
|
|
|||||